Navigation Links
Radiation Therapy Services Holdings, Inc. Acquires Medical Developers, LLC
Date:3/1/2011

FORT MYERS, Fla., March 1, 2011 /PRNewswire/ -- Radiation Therapy Services Holdings, Inc. ("Radiation Therapy") announced today that its wholly-owned subsidiary, Radiation Therapy Services International, Inc., has acquired Medical Developers, LLC ("MDLLC"), the leading private developer and operator of cancer treatment facilities in Latin America.

The total purchase price was approximately $80.0 million, consisting of $47.5 million in cash, $16.25 million in senior subordinated notes and $16.25 million in equity of affiliates of Radiation Therapy. The cash portion was financed through the issuance of $50.0 million of additional senior subordinated notes. Under the terms of the agreement, Radiation Therapy purchased an additional 72% of the business resulting in a 91% ownership interest in the Latin American entities.  MDLLC generated revenues of $53.1 million and pro forma adjusted EBITDA of $17.5 million in 2010, with respective growth rates of 28% and 36%.  

"Medical Developers represents a great fit for Radiation Therapy from both a strategic and financial perspective," said Dr. Daniel Dosoretz, President and Chief Executive Officer.  "With 29 centers in six Latin American countries, MDLLC serves to drive continued growth while also providing geographic and payer diversification.  Additionally, its significant foothold in the regions in which it operates positions Radiation Therapy to capitalize on the growing pipeline of opportunities for de novo centers and acquisitions.  From a financial perspective, MDLLC's strong free cash flow and the structure of the transaction will have a deleveraging effect and further enable us to make investments in our long-term growth."  

About Radiation TherapyRadiation Therapy, which operates radiation treatment centers primarily under the name of 21st Century Oncology, is a provider of advanced radiation therapy services to cancer patients.  The Company's 95 treatment centers are clustered into 28 local markets in 16 states, including Alabama, Arizona, California, Delaware, Florida, Kentucky, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Rhode Island, South Carolina and West Virginia.  The Company is headquartered in Fort Myers, Florida.

RTSXG

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended.  These statements are based on management's current expectations or beliefs about the Company's future plans, expectations and objectives, including, but not limited to, the ability to promptly and effectively integrate the businesses of MDLLC and Radiation Therapy, the possibility that the expected efficiencies and cost savings from the acquisition of MDLLC will not be realized, or will not be realized within the expected time period,  and the Company's ability to accurately estimate its and MDLLC's future financial results and implement its strategies for growth.  These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to the Company's and MDLLC's actual financial results and those risk factors that may be described from time to time in the Company's filings with the Securities and Exchange Commission.  Readers of this release are cautioned not to place undue reliance on forward-looking statements contained herein, which speak only as of the date stated, or if no date is stated, as of the date of this press release. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release, unless required by law.Contact:

Kerrin Gillespie

Chief Financial Officer

Radiation Therapy Services, Inc.

239-938-0971

Kerry.gillespie@rtsx.com Investors:

Amy Glynn / Nick Laudico

The Ruth Group

646-536-7023 / 7030

aglynn@theruthgroup.com

nlaudico@theruthgroup.com
'/>"/>

SOURCE Radiation Therapy Services Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. Beaumont Patients 1st to get Next Generation of Radiation Treatment
3. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
4. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
5. CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
6. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
7. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
8. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
9. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
10. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
11. Breast MRI Scan Could Determine Need for Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017 In China ... is where the Upgrade of China,s ... 13th Five-Year Plan for Economic and Social Development of ... Five-Year Plan), and the state council of the ... national strategic emerging industry development plan, identifying medical devices as ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
(Date:1/18/2017)... , Jan. 18, 2017  Robust competition ... rebates and discounts on medicine prices, according to a ... (BRG). The study is among the first to examine ... companies, generic manufacturers, pharmacy benefit managers (PBMs), health plans ... "The BRG study is the first to show what ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced today ... compete in the Boston Marathon on April 17. From first-time participants to accomplished ... to join Team V and support the Foundation’s mission to declare victory over cancer. ...
(Date:1/18/2017)... ... 18, 2017 , ... Park Agencies Insurance & Financial Services, ... and business owners in the greater Kansas City area, is joining the Lakemary ... The Lakemary Center is a comprehensive educational resource center that provides area children ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. ... website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President ... the field of biosimilars through thought leader interaction in, live video and interactive ...
(Date:1/18/2017)... ... ... Floundering on New Year’s resolutions? Need an excuse to get back on ... U.S. Apple Association agrees and recommends starting each day with apples, a habit ... disease. , The U.S. Apple Association – which represents apple growers and producers nationwide ...
(Date:1/17/2017)... ... January 17, 2017 , ... In the crowded ... is a stand-out company for several differences from other mainstream brands. , ... demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . It allows them ...
Breaking Medicine News(10 mins):